Arnica Echinacea


Uriel Pharmacy Inc.
Human Otc Drug
NDC 48951-1141
Arnica Echinacea is a human otc drug labeled by 'Uriel Pharmacy Inc.'. National Drug Code (NDC) number for Arnica Echinacea is 48951-1141. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Arnica Echinacea drug includes Achillea Millefolium - 6 [hp_X]/mL Aconitum Napellus - 6 [hp_X]/mL Arnica Montana - 6 [hp_X]/mL Atropa Belladonna - 6 [hp_X]/mL Bellis Perennis - 5 [hp_X]/mL Calcium Sulfide - 9 [hp_X]/mL Calendula Officinalis Flowering Top - 6 [hp_X]/mL Comfrey Root - 9 [hp_X]/mL Echinacea, Unspecified - 5 [hp_X]/mL Hamamelis Virginiana Leaf - 5 [hp_X]/mL and more. The currest status of Arnica Echinacea drug is Active.

Drug Information:

Drug NDC: 48951-1141
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Arnica Echinacea
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Arnica Echinacea
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Uriel Pharmacy Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ACHILLEA MILLEFOLIUM - 6 [hp_X]/mL
ACONITUM NAPELLUS - 6 [hp_X]/mL
ARNICA MONTANA - 6 [hp_X]/mL
ATROPA BELLADONNA - 6 [hp_X]/mL
BELLIS PERENNIS - 5 [hp_X]/mL
CALCIUM SULFIDE - 9 [hp_X]/mL
CALENDULA OFFICINALIS FLOWERING TOP - 6 [hp_X]/mL
COMFREY ROOT - 9 [hp_X]/mL
ECHINACEA, UNSPECIFIED - 5 [hp_X]/mL
HAMAMELIS VIRGINIANA LEAF - 5 [hp_X]/mL
MATRICARIA RECUTITA - 6 [hp_X]/mL
MERCURIUS SOLUBILIS - 9 [hp_X]/mL
ST. JOHN'S WORT - 5 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Sep, 2009
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 10 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Uriel Pharmacy Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:2FXJ6SW4PK
U0NQ8555JD
O80TY208ZW
WQZ3G9PF0H
2HU33I03UY
1MBW07J51Q
18E7415PXQ
M9VVZ08EKQ
4N9P6CC1DX
T07U1161SV
G0R4UBI2ZZ
324Y4038G2
UFH8805FKA
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
48951-1141-110 AMPULE in 1 BOX (48951-1141-1) / 1 mL in 1 AMPULE01 Sep, 2009N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses: temporary relief of bruises, sprains and minor cuts.

Product Elements:

Arnica echinacea arnica echinacea water sodium chloride bellis perennis bellis perennis echinacea, unspecified echinacea, unspecified hamamelis virginiana leaf hamamelis virginiana leaf st. john's wort st. john's wort achillea millefolium achillea millefolium aconitum napellus aconitum napellus arnica montana arnica montana atropa belladonna atropa belladonna calendula officinalis flowering top calendula officinalis flowering top matricaria recutita matricaria recutita calcium sulfide calcium sulfide mercurius solubilis mercurius solubilis comfrey root comfrey root

Indications and Usage:

Directions: for oral use.

Warnings:

Warnings: claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. do not use if allergic to any ingredient. consult a doctor before use for serious conditions or if conditions worsen or persist. if pregnant or nursing, consult a doctor before use.

Dosage and Administration:

Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow.

Package Label Principal Display Panel:

Arnicaechinaceaampules

Further Questions:

Questions? call 866.642.2858 uriel, east troy, wi 53120 www.urielpharmacy.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.